发明授权
- 专利标题： 5-HT3 receptor antagonists
- 专利标题（中）： 5-HT3受体拮抗剂
-
申请号： US14415712申请日： 2013-07-16
-
公开(公告)号： US09303045B2公开(公告)日： 2016-04-05
- 发明人: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理商 Matthew J. Russo; David M. Stemerick
- 国际申请： PCT/US2013/050762 WO 20130716
- 国际公布： WO2014/014962 WO 20140123
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D498/04 ; A61K31/537 ; C07D519/00 ; C07D498/08 ; C07D451/12 ; A61K31/19 ; A61K31/5386 ; C07D221/22
摘要：
The present invention provides compounds of the formula: that are 5HT3 receptor antagonists and are therefore useful for the treatment of diseases treatable by inhibition of 5HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
公开/授权文献
- US20150291624A1 5-HT3 RECEPTOR ANTAGONISTS 公开/授权日：2015-10-15
信息查询
